Skip to content or main menu

Erase MS

Fda

Advances in Oral Drugs for Multiple Sclerosis

August 1, 2011

Today, Teva Pharmaceuticals had mixed reports to share regarding laquinimod, an experimental, oral drug for Multiple Sclerosis.

Click here to read more about the clinical study and other oral treatments for Multiple Sclerosis.

Read More »

Find us on Facebook. Follow us on Twitter. YouTube. Pinterest. Subscribe to our RSS feed.

Copyright | Site By Urban Jungle | Powered by Inflight